Navigation Links
Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
Date:10/22/2008

CALGARY, Oct. 22 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Prof. Hardev Pandha of The Royal Surrey Hospital, U.K., entitled "Synergistic Anti-Tumour Activity of Oncolytic Reovirus and Cisplatin in a B16.F10 Mouse Melanoma Model" is scheduled to be presented October 23, 2008 at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. The conference is being held in Geneva, Switzerland, from October 21-24, 2008.

In the study, the researchers examined the in vitro and in vivo oncolytic activity of reovirus in combination with cisplatin against a mouse melanoma cell line. The researchers demonstrated that the combined therapy results in significantly increased cell death in vitro compared to either agent alone. In the mouse model, combined therapy suppressed tumour growth and significantly prolonged median survival time. The researchers concluded that the addition of chemotherapeutic agents can significantly enhance the anti-tumour efficacy of reovirus therapy and justify formal clinical evaluation.

This research supports the ongoing U.K. clinical trial examining the combination of REOLYSIN(R) with carboplatin and paclitaxel (REO 011) in patients with advanced cancers. An abstract covering interim results of the trial is expected to be available tomorrow in the Journal of Immunotherapy, the official journal of the International Society for Biological Therapy of Cancer (iSBTc). A poster presentation which will include current results from the trial is scheduled to be presented at the iSBTc conference in San Diego, CA on November 1, 2008.

The poster will be available today on the Oncolytics website at http://www.oncolyticsbiotech.com.

The EORTC-NCI-AACR symposium is held on an annual basis and is jointly organized by the European Organization for Research and Treatment
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ -- Research Triangle Park-based Cnanoz In...atment water purification system NanoPure(TM) deve...ister of Rural Water Supply, Hon. Minister Viswaru...tial tests, performed at Indian Institute of Techn... the drinking water available in India contains to...
(Date:11/25/2009)...k at Economic Club of Canada , ... Ambassador to Speak at Economic Club of Canada., ...nternational Investment, and Chairman and CEO of t... David Appia go to www.investinfrance.org . , , ... press to discuss recent pro-business initiatives ...
(Date:11/25/2009).../ - Cytochroma today announced the appointment of ...ldt will replace Mr. Ulrik Spork as the Novo A/S r...f Board members remains unchanged at six members. ...to the board and look forward to benefiting from h... to make progress in becoming a leading CKD-focuse...
(Date:11/25/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Brazil Bioethanol Market Analysis and Forec...0165503/Brazil-Bioethanol-Market-Analysis-and-Fore... Analysis and Forecasts to 2013 ,, Summary ,...casts of the global bioethanol market and the Braz...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
... / b3c newswire /  - Rentschler Biotechnolog...organization (CMO) for the development and product...ted operation of a 2,500 L multi-process productio...nine stand-alone GMP suites with volumes of 30, 25...f material for clinical trials and for market supp...
...ices, ST. LOUIS, June 20 Stereotaxis, Inc. (Nasd... senior management team for,North American sales a...,Ruggiero as Senior Vice President, North America....eting Officer at DJ Orthopedics, formerly was,Pres...on, and is a 10-year,veteran at General Electric M...
...at Purdue University are developing a miniature re...ops and personal computers, a cooling technology t...ze of computers. , Unlike conventional cooling sy...nned devices called heat sinks attached to compute...y increase how much heat could be removed, said Su...
Other Biology Technology:Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing 2Stereotaxis Appoints Senior Vice President, North America 2Stereotaxis Appoints Senior Vice President, North America 3Tiny refrigerator taking shape to cool future computers 2Tiny refrigerator taking shape to cool future computers 3
(Date:11/25/2009)...pumps some 250 million liters of blood through the...of the heart have to be extremely durable. The res... chair of the Department of Medicine III at Heidel.... Katus), has discovered a protein that is respons...it, the sarcomere. In cooperation with other resea...
(Date:11/24/2009)...derstanding how sounds associated with Navy sonar ... they hear it at all. , The same type of large i...etect flaws in the space shuttle,s behemoth solid ...side the giant head of a whale. The scans are prov...le,s hearing anatomy using a breakthrough method d...
(Date:11/24/2009)...09) -- The Wildlife Conservation Society (WCS) ann...ining population of Siberian tigers has likely dec...hing and habitat loss. , WCS says th...t needs to be done to protect remaining population... report was released by the Siberian Tiger Monitor...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 1CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 2CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 3CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 4With a Broken Hip Comes Higher Risk for Dying 53648 1With a Broken Hip Comes Higher Risk for Dying 53648 2With a Broken Hip Comes Higher Risk for Dying 53648 3BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 1BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 2BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 3BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn 53643 4
... The United States has embarked on an ambitious p... economically and sustainably produce ethanol from...eft in fields after corn grain harvest, has been i... crop biomass or residue is frequently referred to...lue. However, when returned to the land, this carb...
... MADISON, WI, November 26, 2007- Antibiotic resis...rs around the globe have found antibiotics and oth... and sediments, municipal wastewater, animal manur... article in the November-December issue of Journal... State University (CSU) describe a study to find o...
... Cambridge, MA, November 28, 2007 - Sirtris Pharm...al company focused on discovering and developing s...nounced today that findings in the journal Nature ...candidates that offer a promising, new approach to...etes, by targeting SIRT1, a gene that controls the...
Other Biology News:Limited biofuel feedstock supply? 2Manure management reduces levels of antibiotics and antibiotic resistance genes 2Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging 2Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging 3
Rabbit Anti-MAP3K12 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-Human MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Biology Products: